Clarius Group LLC Sells 220 Shares of Cardinal Health, Inc. (NYSE:CAH)

Clarius Group LLC lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,506 shares of the company’s stock after selling 220 shares during the period. Clarius Group LLC’s holdings in Cardinal Health were worth $296,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the company. Eastern Bank bought a new stake in shares of Cardinal Health in the 3rd quarter worth $25,000. Frazier Financial Advisors LLC raised its position in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares during the last quarter. Hara Capital LLC bought a new position in Cardinal Health during the 3rd quarter valued at about $31,000. AM Squared Ltd purchased a new stake in shares of Cardinal Health during the 3rd quarter valued at about $33,000. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Cardinal Health in the third quarter worth approximately $47,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 0.6 %

Shares of CAH opened at $126.27 on Monday. The firm has a market cap of $30.56 billion, a P/E ratio of 24.57, a PEG ratio of 1.48 and a beta of 0.63. The stock’s 50 day moving average is $120.75 and its two-hundred day moving average is $112.03. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $127.27.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The firm’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.73 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd were paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s dividend payout ratio is presently 39.30%.

Analysts Set New Price Targets

CAH has been the topic of several research reports. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Wells Fargo & Company raised Cardinal Health from an “underweight” rating to an “equal weight” rating and lifted their price objective for the stock from $101.00 to $127.00 in a report on Friday, December 13th. Mizuho assumed coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 target price on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Barclays upped their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $133.29.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.